White Paper

De-Risk And Streamline Your Drug Substance & Drug Product Testing

Laboratory scientists-GettyImages-547131814

Developing a new biologic is a delicate dance between speed, safety, and quality. At each stage, the manufacturing process scales up and potentially changes location, introducing potential delays, cost overruns, and knowledge gaps. Maintaining consistent quality, especially in the drug's critical features (CQAs), is paramount. This is where robust Chemistry, Manufacturing and Control (CMC) practices come in, playing a crucial role throughout the entire journey.

From the very first experiments to long after the drug reaches market, CMC experts provide constant analytical support and in-depth material characterization. Their work ensures smooth transitions as production grows, minimizes risks, and safeguards the drug's quality and consistency. Learn how by meticulously monitoring and understanding the drug's properties at every step, CMC teams pave the way for a successful journey from lab bench to patient.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online

Labcorp Biopharmaceutical CMC Services